Increased levels of cFLIPL can block activation of caspase 8 [42], but would then promote ubiquitination of RIPK1 and NFkB signaling and cell survival, rather than necroptosis, which does not appear to be the case in MS GM [33]. This evidence concerns the gene RIPK1 and myeloid sarcoma.